A carregar...

Glycan biomarkers for Alzheimer disease correlate with T‐tau and P‐tau in cerebrospinal fluid in subjective cognitive impairment

Alzheimer disease (AD) is a devastating disease and a global health problem, and current treatments are only symptomatic. A wealth of clinical studies support that the disease starts to develop decades before the first symptoms appear, emphasizing the importance of studying early changes for improvi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:FEBS J
Main Authors: Schedin‐Weiss, Sophia, Gaunitz, Stefan, Sui, Ping, Chen, Qiushi, Haslam, Stuart M., Blennow, Kaj, Winblad, Bengt, Dell, Anne, Tjernberg, Lars O.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7496940/
https://ncbi.nlm.nih.gov/pubmed/31889402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/febs.15197
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!